Johnson & Johnson Says COVID-19 Booster Shot Yields Promising Results
Johnson & Johnson (J&J) just announced that a booster shot of their COVID-19 vaccine has generated promising immune response in early stage clinical trials.
Johnson & Johnson made the announcement in a press release issued early Wednesday morning about their initial research of a vaccine booster shot.
The study found that those who received a booster shot of the vaccine — as part of the trial — generated virus-fighting antibodies "nine fold higher" than those seen after the initial dose.
The news, of course, is quite promising.
But today's announcement did not mention anything about the effects a booster shot may have in helping to fight the delta variant of COVID-19.
Johnson & Johnson says they're engaging with the FDA and other health authorities to discuss the possibility of a booster shot.
The CDC has previously said that those who received the J&J vaccine will probably need a booster dose, but they say that there is not enough data to formally recommend it at this time.